Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.
about
Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.Association between Cerebral Amyloid Deposition and Clinical Factors Including Cognitive Function in Geriatric Depression: Pilot Study Using Amyloid Positron Emission Tomography.Beta-amyloid deposition in patients with major depressive disorder with differing levels of treatment resistance: a pilot study.Depressive Symptoms are Associated with Progression to Dementia in Patients with Amyloid-Positive Mild Cognitive Impairment.Cerebrospinal Fluid Aβ42 Levels: When Physiological Become Pathological State.Monoaminergic neuropathology in Alzheimer's disease.Implementation of subjective cognitive decline criteria in research studies.Abnormal functional connectivity of the posterior cingulate cortex is associated with depressive symptoms in patients with Alzheimer's disease.Effect of CR1 Genetic Variants on Cerebrospinal Fluid and Neuroimaging Biomarkers in Healthy, Mild Cognitive Impairment and Alzheimer's Disease Cohorts.Depressive and anxiety symptoms and cortical amyloid deposition among cognitively normal elderly persons: the Mayo Clinic Study of Aging.Amyloid burden and incident depressive symptoms in cognitively normal older adults.Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment.Cognitive Impairment and Structural Abnormalities in Late Life Depression with Olfactory Identification Impairment: an Alzheimer's Disease-Like Pattern.
P2860
Q36910036-9253B4BE-AE0C-470A-81C1-63617FA71001Q37373662-7F884C90-ECEC-4851-8DD5-B7E9357DFAB6Q37714491-1FF40248-646D-4BA5-8EBA-A6BBE8BD12B4Q38402481-ABFB1786-F948-45C4-A0EB-B4C81BDF69DEQ38629788-B3663D16-ED4D-42D9-97BF-8C9422CF3866Q38809649-D6238418-7431-4741-A251-1CB60CF47C5CQ40483941-A19E98F7-133E-42E4-8A44-1845BF5270E0Q42688369-700BD952-EB0B-4240-8D6D-086C33D39163Q46359830-36BF1BBA-D6BB-4029-9D5A-C9CD38E4201DQ47689619-849764E5-1F8E-4470-9805-3B4B09E8C8E6Q48036045-01713429-3DC7-4FB7-A4C0-5022F49BB895Q50535439-2F112A1B-B3AE-4CDC-AE7E-FA51FB245BF5Q55518683-92BD78B6-02B0-469D-BB4B-306E07DDB132
P2860
Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.
@en
Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.
@nl
type
label
Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.
@en
Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.
@nl
prefLabel
Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.
@en
Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.
@nl
P2093
P2860
P1476
Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.
@en
P2093
Andreas Delker
Axel Rominger
Guoming Xiong
Matthias Brendel
Peter Bartenstein
P2860
P2888
P304
P356
10.1007/S00259-014-2975-4
P577
2015-01-29T00:00:00Z